Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings
- PMID: 36753705
- DOI: 10.1097/QCO.0000000000000895
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings
Abstract
Purpose of review: Point-of-care (POC) testing for sexually transmitted infections (STIs) can provide complementary coverage to existing HIV testing services in LMICs. This review summarizes current and emerging technologies for detecting STIs in LMICs, with an emphasis on women, discharge-causing infections (chlamydia, gonorrhoea, trichomoniasis, and syphilis), true POC, self-testing, ethics, and economic considerations related to equitable access.
Recent findings: The WHO have recently adapted guidelines for treatment of STIs in women that advise the use of true-POC or near-POC tests to improve case finding. The number of rapid, sensitive, and specific POC diagnostics for STIs has increased significantly over the past 10 years, although adoption of these in low-income and middle-income countries (LMICs) remains limited. Barriers to POC adoption by patients include the cost of tests, the inconvenience of lengthy clinic visits, low perceived risk, stigma, lack of partner notification, and lack of trust in healthcare providers. Lowering the cost of true POC lateral flow devices, interfacing these with digital or eHealth technologies, and enabling self-testing/self-sampling will overcome some of these barriers in LMICs. Ensuring linkage of diagnostic tests to subsequent care remains one of the major concerns about self-testing, irrespective of geography, although available evidence from HIV self-testing suggests that linkage to care is similar to that for facility-based testing.
Summary: Increasing access to sensitive STI true POC tests will strengthen reproductive healthcare in LMICs. Although HIV self-testing is demonstrably useful in LMICs, there is an urgent need for randomized trials evaluating the utility and cost-effectiveness of similar tests for other sexually transmitted infections.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Cost and cost-effectiveness of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low-income and middle-income countries: a systematic review protocol.BMJ Open. 2019 Nov 14;9(11):e029945. doi: 10.1136/bmjopen-2019-029945. BMJ Open. 2019. PMID: 31727649 Free PMC article.
-
Facilitators and barriers to point-of-care testing for sexually transmitted infections in low- and middle-income countries: a scoping review.BMC Infect Dis. 2022 Jun 20;22(1):561. doi: 10.1186/s12879-022-07534-9. BMC Infect Dis. 2022. PMID: 35725437 Free PMC article.
-
Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control.Curr Opin Infect Dis. 2013 Feb;26(1):73-9. doi: 10.1097/QCO.0b013e32835c21b0. Curr Opin Infect Dis. 2013. PMID: 23242343 Free PMC article. Review.
-
Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections.Lab Chip. 2022 Feb 1;22(3):476-511. doi: 10.1039/d1lc00665g. Lab Chip. 2022. PMID: 35048928 Free PMC article. Review.
-
Attitudes of women participating in a clinical trial on point-of-care testing and home testing for STIs.Int J STD AIDS. 2020 Dec;31(14):1352-1358. doi: 10.1177/0956462420955067. Epub 2020 Sep 30. Int J STD AIDS. 2020. PMID: 32996866
Cited by
-
Nurses' perspectives on user-friendly self-sampling interventions for diagnosis of sexually transmitted infections among young women in eThekwini district municipality: a nominal group technique.BMC Health Serv Res. 2024 Jan 18;24(1):106. doi: 10.1186/s12913-023-10353-6. BMC Health Serv Res. 2024. PMID: 38238703 Free PMC article.
-
Shifting Grounds-Facilitating Self-Care in Testing for Sexually Transmitted Infections Through the Use of Self-Test Technology: Qualitative Study.J Particip Med. 2024 Aug 14;16:e55705. doi: 10.2196/55705. J Particip Med. 2024. PMID: 39141903 Free PMC article.
References
-
- Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 2019; 97:548–562.
-
- Martin K, Wenlock R, Roper T, et al. Facilitators and barriers to point-of-care testing for sexually transmitted infections in low- and middle-income countries: a scoping review. BMC Infect Dis 2022; 22:561.
-
- Adamson PC, Loeffelholz MJ, Klausner JD. Point-of-care testing for sexually transmitted infections: a review of recent developments. Arch Pathol Lab Med 2020; 144:1344–1351.
-
- Adachi K, Xu J, Yeganeh N, et al. NICHD HPTN 040 Study Team. Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission. PLoS One 2018; 13:e0189851.
-
- Mlisana K, Naicker N, Werner L, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012; 206:6–14.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous